The phase 1 trial, VNA-318-01, was a randomized, double-blind study involving 92 healthy male subjects. Interim results ...

Draig Therapeutics has announced the appointment of Ivana Magovčević-Liebisch as President and Chief Executive Officer. She ...

SERB Pharmaceuticals has appointed Dr Vignesh Rajah as its new Chief Medical Officer, bringing over 20 years of global ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Amvuttra ...

Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, ...

Xmoor Pharma and Royal Free London NHS Foundation Trust have announced a strategic collaboration to create a seamless pathway ...

Bayer has reported encouraging topline findings from its global phase 3 OCEANIC-STROKE study, evaluating the investigational ...

The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...

GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...

Two became one at the Grand Connaught Rooms in London as a joyous jamboree of marketing and communications excellence, all ...

The Health Service Executive (HSE) has approved BIMZELEX (bimekizumab) in Ireland for adults living with moderate-to-severe ...

The old model of ‘pushing’ a message is dead. The new game is about earning trust, proving your humanity and co-creating.